Abstract
Background
Non-alcoholic fatty liver disease (NAFLD) is the liver manifestation of metabolic syndrome, a risk factor for mortality and cardiovascular morbidity, but we ignore the role of steatosis per se in survival, and there is very little information about this condition in the geriatric patient.
Aims
With the present study, we investigated the independent prognostic value of NAFLD on overall mortality in the elderly.
Methods
Within the Pianoro Project, involving people ≥ 65 years, anamnestic, clinical and laboratoristic data related to NAFLD, insulin resistance, diabetes/hyperglycemia, hypertension, obesity and dyslipidemia were collected in 804 subjects (403 male, 401 female). These subjects were followed up for mortality for a median time of 12.6 years. A multivariate analysis was performed to evaluate the prognostic value of the covariates.
Results
At Kaplan–Meier estimator the presence of NAFLD seems to be associated to a lower mortality, and survival tends to increase with the increasing of steatosis grade. Cox’s analysis found that survival is increased for subjects having hypercholesterolemia (RR = 0.565), NAFLD (RR = 0.777), hypertension (RR = 0.711) and in female (RR = 0.741), while it is decreased for the older subjects (RR = 3.046), in patients with hypertriglyceridemia (RR = 1.699) and for diabetics (RR = 1.797). The variables BMI and HDL-cholesterol have no role.
Conclusion
The data obtained in our study show that NAFLD is not associated to overall mortality in the elderly population.
Similar content being viewed by others
References
Marchesini G, Day CP, Dufour JF et al (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. https://doi.org/10.1016/j.jhep.2015.11.004
McCullough AJ (2006) Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol. https://doi.org/10.1097/01.mcg.0000168645.86658.22
Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Pharmacol Ther Aliment. https://doi.org/10.1111/j.1365-2036.2011.04724.x
Neuschwander-Tetri BA (2005) Nonalcoholic steatohepatitis and the metabolic syndrome. BMC Med. https://doi.org/10.1186/s12916-017-0806-8
Adams LA, Angulo P (2005) Recent concepts in non-alcoholic fatty liver disease. Med Diabet. https://doi.org/10.1111/j.1464-5491.2005.01748.x
Marchesini G, Bugianesi E, Forlani G et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. https://doi.org/10.1053/jhep.2003.50161
Lonardo A, Ballestri S, Marchesini G et al (2015) Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. https://doi.org/10.1016/j.dld.2014.09.020
Frith J, Day CP, Robinson L et al (2010) Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol. https://doi.org/10.1016/j.jhep.2009.10.010
Hong HC, Hwang SY, Choi HY et al (2014) Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study. Hepatology. https://doi.org/10.1002/hep.26716
Kitajima Y, Eguchi Y, Ishibashi E et al (2010) Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol. https://doi.org/10.1007/s00535-009-0147-2
Franceschi C, Campisi J (2014) Chronic inflammation (Inflammaging) and its potential contribution to age-associated diseases. Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glu057
Beyer I, Mets T, Bautmans I (2012) Chronic low-grade inflammation and age-related sarcopenia. Opin Clin Nutr Metab Care Curr. https://doi.org/10.1097/MCO.0b013e32834dd297
Bertolotti M, Lonardo A, Mussi C et al (2014) Nonalcoholic fatty liver disease and aging: epidemiology to management. Gastroenterol World J. https://doi.org/10.3748/wjg.v20.i39.14185
Brea A, Mosquera D, Martín E et al (2005) Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/01.ATV.0000160613.57985.18
Abbatecola AM, Ferrucci L, Marfella R, Paolisso G (2007) Insulin resistance and cognitive decline may be common soil for frailty syndrome. Intern Med Arch. https://doi.org/10.1001/archinte.167.19.2145-b
Pi-Sunyer FX, Becker DM, Bouchard C et al (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. https://doi.org/10.1093/ajcn/68.4.899
Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care. https://doi.org/10.2337/diacare.20.7.1087
Bugianesi E, Gastaldelli A, Vanni E et al (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. https://doi.org/10.1007/s00125-005-1682-x
Bugianesi E, Pagotto U, Manini R et al (2005) Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2004-2240
Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. https://doi.org/10.1016/0021-9681(87)90171-8
Siri WE (1993) Body composition from fluid spaces and density: analysis of methods. 1961. Nutrition 9:480–491
Ekstedt M, Franzén LE, Mathiesen UL et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. https://doi.org/10.1002/hep.21327
Zeb I, Li D, Budoff MJ et al (2016) Nonalcoholic fatty liver disease and incident cardiac events the multi-ethnic study of atherosclerosis. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2016.01.07
Agricola E, Bove T, Oppizzi M et al (2005) “Ultrasound comet-tail images”: a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water. Chest 127:1690–1695. https://doi.org/10.1378/chest.127.5.1690
Bedogni G, Miglioli L, Masutti F et al (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study. Hepatology. https://doi.org/10.1002/hep.20734
Kagansky N, Levy S, Keter D et al (2004) Non-alcoholic fatty liver disease—a common and benign finding in octogenarian patients. Liver Int. https://doi.org/10.1111/j.1478-3231.2004.0969.x
Koehler EM, Schouten JNL, Hansen BE et al (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol. https://doi.org/10.1016/j.jhep.2012.07.028
Bangalore S, Gong Y, Cooper-Dehoff RM et al (2014) 2014 eighth joint national committee panel recommendation for blood pressure targets revisited: results from the invest study. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2014.05.044
Schatz IJ, Masaki K, Yano K et al (2001) Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet. https://doi.org/10.1016/S0140-6736(01)05553-2
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Statement of human and animal rights
All procedures and the research protocol have been approved by the locally appointed ethics committee of the University of Bologna. The experimental protocol was designed in accordance with the Declaration of Helsinki (1964).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tallarico, V., Recinella, G., Magalotti, D. et al. Prognostic value of non-alcoholic fatty liver disease in the elderly patients. Aging Clin Exp Res 32, 2657–2665 (2020). https://doi.org/10.1007/s40520-020-01487-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-020-01487-2